🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
Fat/Fatty Acid Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Evening Primrose Oil
1000 mg

Other Ingredients

Gelatin Vegetable Glycerin

Label Claims — Verification

Nutrient
All Other
Structure/Function

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: For adults, take one (1) softgel three times daily, preferably with a meal.

⚠️ Warnings & Precautions

Warning: If your are pregnant, nursing, taking any medications or planning any medical procedure, consult your doctor if any adverse reactions occur.

Keep out of reach of children.

Tamper resistant: Do not use if imprinted seal under cap is broken or missing.

🧪 Formulation Notes

Evening primose is a natural source of the unsaturated fatty acid, gamma-linolenic acid (GLA), that promotes women's health and helps provide nutritional support for PMS.

No artificial color, flavor or sweetener, no preservatives, no sugar, no starch, no milk, no lactose, no soy, no gluten, no wheat, no yeast, no fish. Sodium free.

Standardized GLA 9% Providing 90 mg GLA(9%)

Promotes women's health Natural support for women with PMS

Additional Information

Body Integrated health Naturally driven for long lasting health.

Body

Made in USA

Store in a dry place and avoid excessive heat.

Product Details

UPC / SKU 6 41399 08327 6
DSLD Entry Date 2018-07-25
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 178627
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.